Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Net Income Growth
21.14%
TTM · Period ending:
LCTX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported21.14%period ending
Latest reported21.14%period ending
LCTX TTM Net Income YoY % (-20.00% → 21.14%)
Year-over-year change
High-resolution chart · PNG
LCTX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 32.3895% | |
| 25.296% | |
| 11.7361% | |
| -2.9721% | |
| -73.7728% | |
| -60.5219% | |
| -44.4444% | |
| -5.7143% | |
| -2.7027% | |
| -9.0909% | |
| -16.6667% | |
| -48% | |
| -19.2308% | |
| -37.5% | |
| -50% | |
| -13.6364% | |
| -18.1818% | |
| -9.0909% | |
| 16.6667% | |
| -4.7619% | |
| -22.2222% | |
| -37.5% | |
| -71.4286% | |
| -61.5385% | |
| -50% | |
| -45.4545% | |
| -27.2727% | |
| -30% | |
| -20% |